MedTrace Logo

Comparing the Effect of Sitagliptin/Metformin and Metformin in PCOS Patients

NCT04268563 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-03-22

No results posted yet for this study

Summary

Investigators will evaluate and compare the efficacy of Sitagliptin/Metformin to metformin and sitagliptin on gdf9 and bmp15 gene expression on PCOS patients undergoing intracytoplasmic sperm injection(ICSI).

Conditions

Interventions

DRUG

placebo

Oral rehydration solution

DRUG

metformin

metformin tablet

DRUG

Sitagliptin

Sitagliptin tablet

DRUG

Sitagliptin/metformin

Sitagliptin/metformin tablet

Sponsors & Collaborators

  • Shahid Beheshti University of Medical Sciences

    lead OTHER

Principal Investigators

  • Shahrzad Shahrzad Zadehmodarres, Professor · Shahid Beheshti University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-10
Primary Completion
2021-07-19
Completion
2021-07-30

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04268563 on ClinicalTrials.gov